结直肠癌肝转移的发生机制

被引:19
作者
方淯靖
万德森
机构
[1] 华南肿瘤学国家重点实验室
关键词
结直肠肿瘤; 肝肿瘤/继发性; 分子机制;
D O I
暂无
中图分类号
R735.3 [肠肿瘤];
学科分类号
100112 [医学生物化学与分子生物学];
摘要
结直肠癌的发病率及死亡率在全世界以每年递增的趋势发展着,而其主要的死亡原因是肝转移。这一事件引起了众多学者的关注,大量研究也从各方面对其机理进行了论证。我们应用PubMed和MedLine,以及中国期刊网全文数据库(CNKI)两大文献检索文库,用"结直肠癌"、"肝转移"、"分子机制"等关键词进行检索,总结了近十年间有关结直肠癌的研究,试图提供一个结直肠癌肝转移的基本框架。本文中重点分析一些可能控制此事件的关键分子,对8类13项分子指标,包括基质金属蛋白酶、尿激酶型纤溶酶原激活剂受体、整合素、骨桥蛋白、肿瘤坏死因子相关凋亡诱导配体、干扰素-β、胰岛素样生长因子Ⅰ型受体、核基质蛋白、血管上皮生长因子、过氧化物酶体增殖物激活受体、胰岛素样生长因子、细胞外信号调节激酶和蛋白酶活化受体等与结直肠癌之间的关系进行了总结和分析,以期为寻找治疗和预测结直肠癌肝转移的新靶点提供新思路。
引用
收藏
页码:549 / 554
页数:6
相关论文
共 20 条
[1]
Metastatic ability of Drosophila tumors depends on MMP activity [J].
Beaucher, Michelle ;
Hersperger, Evelyn ;
Page-McCaw, Andrea ;
Shearn, Allen .
DEVELOPMENTAL BIOLOGY, 2007, 303 (02) :625-634
[2]
Hyperbaric oxygen therapy for malignancy: A review [J].
Daruwalla, Jurstine ;
Christophi, Chris .
WORLD JOURNAL OF SURGERY, 2006, 30 (12) :2112-2131
[3]
Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity [J].
Ishizaki, T ;
Katsumata, K ;
Tsuchida, A ;
Wada, T ;
Mori, Y ;
Hisada, M ;
Kawakita, H ;
Aoki, T .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (02) :357-362
[4]
The role of osteopontin in tumor metastasis [J].
Wai, PY ;
Kuo, PC .
JOURNAL OF SURGICAL RESEARCH, 2004, 121 (02) :228-241
[5]
Osteopontin identified as colon cancer tumor progression marker.[J].Deepak Agrawal;Tingan Chen;Rosalyn Irby;John Quackenbush;Ann F Chambers;Marianna Szabo;Alan Cantor;Domenico Coppola;Timothy J Yeatman.Comptes rendus - Biologies.2003, 10
[6]
Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice [J].
Osawa, E ;
Nakajima, A ;
Wada, K ;
Ishimine, S ;
Fujisawa, N ;
Kawamori, T ;
Matsuhashi, N ;
Kadowaki, T ;
Ochiai, M ;
Sekihara, H ;
Nakagama, H .
GASTROENTEROLOGY, 2003, 124 (02) :361-367
[7]
Osteopontin and colon cancer progression [J].
Yeatman, TJ ;
Chambers, AF .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (01) :85-90
[8]
PPARγ ligands:: Taking Ppart in chemoprevention [J].
Girnun, GD ;
Spiegelman, BM .
GASTROENTEROLOGY, 2003, 124 (02) :564-567
[9]
Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166 [J].
Oba, K ;
Konno, H ;
Tanaka, T ;
Baba, M ;
Kamiya, K ;
Ohta, M ;
Kaneko, T ;
Shouji, T ;
Igarashi, A ;
Nakamura, S .
CANCER LETTERS, 2002, 175 (01) :45-51
[10]
Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells [J].
Zimmer, R ;
Thomas, P .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (06) :541-550